Sign up to save your podcasts
Or
Share Psychedelics Bill Vetoed In California Real Shame
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Psychedelics Bill Vetoed In California Real Shame
Today's Daily Dose is partly brought to you by
Grassdoor.com cannabis delivered fast SAVE 40% OFF Your Entire Purchase USE CODE: DAILY @ Checkout and
by Social CBD discover the power of this cannabinoid it may aid with stress, mood and sleep
https://socialcbd.pxf.io/n1GAJo
by Audible discover and enjoy a vast collection of audiobooks, stories and more save now on your first months subscription.
https://www.audibletrial.com/e462rj
If you want to help support this channel and the content please consider checking out my website TheDailyDose.co
You can also checkout these Top 5 Best Natural Health Remedies
https://5bestnaturalremedies.com/?id=6411ea08fb3fa87c9ee0f0b3
Introduction
California, known for its progressive stance on various social and cultural issues, recently found itself at a crossroads when Governor Gavin Newsom vetoed a bill aimed at decriminalizing the possession and personal use of hallucinogens.
This decision has sparked debates and discussions across the state, as it has implications not only for California but also for the broader conversation surrounding psychedelics and their therapeutic potential.
The Veto Decision
In a statement, Governor Newsom expressed his reservations about the bill, highlighting the need for regulated treatment guidelines, therapeutic guidelines, and rules to prevent exploitation during guided treatments.
He argued that decriminalizing possession should only occur after these guidelines are firmly in place. This decision has left many wondering about the future of psychedelics in California.
The Current Landscape of Psychedelics
Recent years have seen a resurgence of interest in psychedelics as an alternative approach to treating various mental illnesses, including post-traumatic stress disorder (PTSD) and treatment-resistant depression.
The Federal Drug Administration (FDA) recognized psilocybin as a "breakthrough therapy" for treatment-resistant depression in 2019. Moreover, the draft guidelines published by the FDA on using psychedelics in clinical trials have further highlighted their therapeutic potential.
#magicmushrooms #psilocybin #mentalhealth #californiabill #californialaw #hallucinagens #thedailydosepodcast #podcast #alternativehealing #plantmedicines
View all episodes
By The Daily Dose PodcastToday's Daily Dose is partly brought to you by
Grassdoor.com cannabis delivered fast SAVE 40% OFF Your Entire Purchase USE CODE: DAILY @ Checkout and
by Social CBD discover the power of this cannabinoid it may aid with stress, mood and sleep
https://socialcbd.pxf.io/n1GAJo
by Audible discover and enjoy a vast collection of audiobooks, stories and more save now on your first months subscription.
https://www.audibletrial.com/e462rj
If you want to help support this channel and the content please consider checking out my website TheDailyDose.co
You can also checkout these Top 5 Best Natural Health Remedies
https://5bestnaturalremedies.com/?id=6411ea08fb3fa87c9ee0f0b3
Introduction
California, known for its progressive stance on various social and cultural issues, recently found itself at a crossroads when Governor Gavin Newsom vetoed a bill aimed at decriminalizing the possession and personal use of hallucinogens.
This decision has sparked debates and discussions across the state, as it has implications not only for California but also for the broader conversation surrounding psychedelics and their therapeutic potential.
The Veto Decision
In a statement, Governor Newsom expressed his reservations about the bill, highlighting the need for regulated treatment guidelines, therapeutic guidelines, and rules to prevent exploitation during guided treatments.
He argued that decriminalizing possession should only occur after these guidelines are firmly in place. This decision has left many wondering about the future of psychedelics in California.
The Current Landscape of Psychedelics
Recent years have seen a resurgence of interest in psychedelics as an alternative approach to treating various mental illnesses, including post-traumatic stress disorder (PTSD) and treatment-resistant depression.
The Federal Drug Administration (FDA) recognized psilocybin as a "breakthrough therapy" for treatment-resistant depression in 2019. Moreover, the draft guidelines published by the FDA on using psychedelics in clinical trials have further highlighted their therapeutic potential.
#magicmushrooms #psilocybin #mentalhealth #californiabill #californialaw #hallucinagens #thedailydosepodcast #podcast #alternativehealing #plantmedicines